Skip to main content

Advertisement

SpringerLink
Log in

Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs

  • Review
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Transcatheter closure of atrial septum defect (ASD) with a closure device is increasing, but the history of clinical use of this procedure is still short, and the efficacy and long-term safety remain unproved. The total number of closure devices implanted throughout the world has not been counted accurately. Therefore, the probability of complications occurring after implantation is uncertain. Device-related complications that occur suddenly late after implantation are life-threatening, and quite often necessitate emergency surgical intervention. In Japanese medical journals, authors reporting closure devices have mentioned no complications and problems in their facilities. Detailed studies of device-related complications and device removal have not been reported in Japan. In fact, this literature search found an unexpectedly large number of reports of various adverse events from many overseas countries. When follow-up duration is short and the number of patients is small, the incidence of complications cannot be determined. Rare complications may emerge in a large series with a long observation period. Consequently, the actual number of incidents related to ASD closure devices is possibly several times higher than the number reported. Guidelines for long-term patient management for patients with an implanted closure device are necessary and post-marketing surveillance is appropriate. Development of a national database, a worldwide registration system, and continuous information disclosure will improve the quality of treatment. The devices currently available are not ideal in view of reports of late complications requiring urgent surgery and the need for life-long follow-up. An ideal device should be free from complications during life, and reliability is indispensable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tateishi M, Tomizawa Y. Intravascular foreign bodies: danger of unretrieved fragmented medical devices. J Artif Organs. 2009;12:80–9.

    Article  PubMed  Google Scholar 

  2. Walsh KP, Tofeig M, Kitchiner DJ, Peart I, Arnold R. Comparison of the Sideris and Amplatzer septal occlusion devices. Am J Cardiol. 1999;83:933–6.

    Article  PubMed  CAS  Google Scholar 

  3. Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol. 2005;45:505–7.

    Article  PubMed  Google Scholar 

  4. Berger F, Vogel M, Alexi-Meskishvili V, Lange PE, Crawford FA Jr, Rome JJ. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg. 1999;118:674–80.

    Article  PubMed  CAS  Google Scholar 

  5. Yew G, Wilson NJ. Transcatheter atrial septal defect closure with the amplatzer septal occluder: five-year follow-up. Catheter Cardiovasc Interv. 2005;64:193–6.

    Article  PubMed  Google Scholar 

  6. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39:1836–44.

    Article  PubMed  Google Scholar 

  7. Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, Pomè G, Bossone E, Frigiola A. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J. 2006;151:228–34.

    Article  PubMed  Google Scholar 

  8. Tateishi M, Hiramatsu T, Tomizawa Y, Matsumura G, Konuma T, Yamazaki K, Yamamura H, Nakanishi T. Cardiac tamponade due to perforation by an Amplatzer atrial septal occluder in a patient with Marfan syndrome. J Artif Organs. 2011;14:261–3.

    Article  PubMed  Google Scholar 

  9. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976;235:2506–9.

    Article  PubMed  CAS  Google Scholar 

  10. Rashkind WJ. Transcatheter treatment of congenital heart disease. Circulation. 1983;67:711–6.

    Article  PubMed  CAS  Google Scholar 

  11. Das GS, Voss G, Jarvis G, Wyche K, Gunther R, Wilson RF. Experimental atrial septal defect closure with a new, transcatheter, self-centering device. Circulation. 1993;88:1754–64.

    Article  PubMed  CAS  Google Scholar 

  12. Mills NL, King TD. Late follow-up of nonoperative closure of secundum atrial septal defects using the King–Mills double-umbrella device. Am J Cardiol. 2003;92:353–5.

    Article  PubMed  Google Scholar 

  13. Agarwal SK, Ghosh PK, Mittal PK. Failure of devices used for closure of atrial septal defects: mechanisms and management. J Thorac Cardiovasc Surg. 1996;112:21–6.

    Article  PubMed  CAS  Google Scholar 

  14. Sharafuddin MJA, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ, Amplatz K. Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation. 1997;95:2162–8.

    Article  PubMed  CAS  Google Scholar 

  15. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997;42:388–94.

    Article  PubMed  CAS  Google Scholar 

  16. Zahn EM, Wilson N, Cutright W, Latson LA. Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation. 2001;104:711–6.

    Article  PubMed  CAS  Google Scholar 

  17. Koike K, Echigo S, Kumate M, Kobayashi T, Isoda T, Ishii M, Ishizawa A, Kamiya T, Kato H. Transcatheter closure of atrial septal defect with a prototype clamshell septal umbrella: one year follow-up. J Cardiol. 1994;24:53–60. in Japanese.

    PubMed  CAS  Google Scholar 

  18. Kobayashi T, Koike K, Echigo S, Tomita H, Nakanishi T. Transcatheter intervention using Angel wings atrial septum defect closing device: mid-term results. Pediatr Cardiol Cardiac Surg. 1999;15:305. in Japanese.

    Google Scholar 

  19. Oho S, Ishizawa A, Akagi T, Dodo H, Kato H. Transcatheter closure of atrial septal defects with the Amplatzer septal occluder: a Japanese clinical trial. Circ J. 2002;66:791–4.

    Article  PubMed  Google Scholar 

  20. Yasukochi S. Current status of transcatheter closure of atrial septal defect. Respir Circ. 2009;57:1305–10. in Japanese.

    Google Scholar 

  21. Ishido H, Kobayashi T, Matsunaga T. Transitory pericardial effusion after implantation of Amplatzer septal occluder (ASO): two cases of atrial septal defect (ASD). Pediatr Cardiol Cardiac Surg. 2009;25:206. in Japanese.

    Google Scholar 

  22. Enomoto N, Yasunaga H, Sakashita H, Shojima T, Todo K. Late cardiac perforation after atrial septal defect closure with the Amplatzer septal occluder. Jpn J Cardiovasc Surg. 2008;37:341–4. in Japanese.

    Article  Google Scholar 

  23. Katsube T, Hiramatsu T, Matsumura G, Konuma T, Tateishi M, Sugimoto K, Ookura M, Toyoda Y, Saso M, Isomura S, Tomizawa Y, Saito H, Yamazaki K. Cases requiring surgical device removal associated with transcatheter atrial septal defect closing procedure. Jpn J Cardiovasc Surg. 2012;41:369. In Japanese.

    Google Scholar 

  24. Fujita Y, Akagi T, Oozawa S, Kawabata T, Kuroko Y, Tateishi A, Takagaki M, Arai S, Kasahara S, Sano S. Investigation of complications after transcatheter closure of atrial septal defect. Jpn J Cardiovasc Surg. 2012;41:369. in Japanese.

    Google Scholar 

  25. Sakamoto T, Nakanishi T, Ishihara K, Iwata Y, Matsumura G, Yamamoto N, Mori Y, Yamamura H, Tomimatsu H, Kurosawa H. Current state after Amplatzer device closure introduction in atrium septal defect at our hospital. Pediatr Cardiol Cardiac Surg. 2008;24:316. in Japanese.

    Google Scholar 

  26. Kosaka Y, Aso T, Takeda Y, Kajihara Y, Matsuhama M, Onakatomi Y. Current state after Amplatzer device closure introduction in atrium septal defect at our hospital. Pediatr Cardiol Cardiac Surg. 2009;25:830. in Japanese.

    Google Scholar 

  27. Ueda H, Sekine K, Iwaoka A, Miyata D, Yanagi M, Yasui M, Matsuhama M, Kajihara Y, Kosaka Y, Takeda Y, Aso T. Amplatzer septal occluder (ASO) in atrial septum defect treatment: comparison of safety and economic effectuations with surgical operation. Pediatr Cardiol Cardiac Surg. 2009;25:329. in Japanese.

    Google Scholar 

  28. Kobayashi T. Device closure in ASD/PFO: recent findings. In: Yamaguchi T, Takamoto S, Komuro I, Saji T, editors. Annual review in cardiology 2011. Tokyo: Chugai Igakusha; 2011. p. 270–6. in Japanese.

    Google Scholar 

  29. Cooke JC, Gelman JS, Harper RW. Cobrahead malformation of the Amplatzer septal occluder device: an avoidable complication of percutaneous ASD closure. Catheter Cardiovasc Interv. 2001;52:83–5.

    Article  PubMed  CAS  Google Scholar 

  30. Mazic U, Gavora P, Masura J. “Cobra-like” deformation of an amplatzer septal occluder. Pediatr Cardiol. 2001;22:253–4.

    Article  PubMed  CAS  Google Scholar 

  31. Harper RW, Mottram PM, McGaw DJ. Closure of secundum atrial septal defects with the Amplatzer septal occluder device: techniques and problems. Catheter Cardiovasc Interv. 2002;57:508–24.

    Article  PubMed  Google Scholar 

  32. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart. 2003;89:199–204.

    Article  PubMed  CAS  Google Scholar 

  33. Cao QL, Du ZD, Joseph A, Koenig P, Heitschmidt M, Rhodes J, Hijazi ZM. Immediate and six-month results of the profile of the Amplatzer septal occluder as assessed by transesophageal echocardiography. Am J Cardiol. 2001;88:754–9.

    Article  PubMed  CAS  Google Scholar 

  34. Vogt MO, Kühn A, Hörer J, Schreiber C, Schneider H, Foth R, Eicken A, Hess J, Sigler M. Clinical, echocardiographic and histopathologic findings in nine patients with surgically explanted ASD/PFO devices: do we know enough about the healing process in humans? Int J Cardiol. 2011;147:398–404.

    Article  PubMed  Google Scholar 

  35. Bohm J, Bittigau K, Köhler F, Baumann G, Konertz W. Surgical removal of atrial septal defect occlusion system-devices. Eur J Cardiothorac Surg. 1997;12:869–72.

    Article  PubMed  CAS  Google Scholar 

  36. Kitano M, Yazaki S, Sugiyama H, Yamada O. The influence of morphological changes in amplatzer device on the atrial and aortic walls following transcatheter closure of atrial septal defects. J Intervent Cardiol. 2009;22:83–91.

    Article  PubMed  Google Scholar 

  37. Prieto LR, Foreman CK, Cheatham JP, Latson LA. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the bard clamshell septal umbrella. Am J Cardiol. 1996;78:1310–2.

    Article  PubMed  CAS  Google Scholar 

  38. Carminati M, Giusti S, Hausdorf G, Qureshi S, Tynan M, Witsenburg M, Hess J, Piechaud JF, Bonhoeffer P, Donti A, Ovaert C, Sievert H, Elzenga N, Talsma M, Van Oort A, Ernst J, Gewillig M, De Geeter B. A European multicentric experience using the CardioSEAL® and Starflex double umbrella devices to close interatrial communications holes within the oval fossa. Cardiol Young. 2000;10:519–26.

    Article  PubMed  CAS  Google Scholar 

  39. Pedra CAC, Pihkala J, Lee KJ, Boutin C, Nykanen DG, McLaughlin PR, Harrison DA, Freedom RM, Benson L. Transcatheter closure of atrial septal defects using the Cardio-Seal implant. Heart. 2000;84:320–6.

    Article  PubMed  CAS  Google Scholar 

  40. Kreutzer J, Ryan CA, Gauvreau K, Van Praagh R, Anderson JM, Jenkins KJ. Healing response to the clamshell device for closure of intracardiac defects in humans. Catheter Cardiovasc Interv. 2001;54:101–11.

    Article  PubMed  CAS  Google Scholar 

  41. Chowdhury PS, Ramos RG. Coronary-stent fracture. N Engl J Med. 2002;347:581.

    Article  PubMed  Google Scholar 

  42. Fagan T, Dreher D, Cutright W, Jacobson J, Latson L, Badran S, Chan KC, Crowley C, DeMoor M, Patel H, Fleismann C, Ing F, Jones T, Javois A, Pignatelli R, Rhodes J, Rome J, Saba Z, Vincent R, Zahn E, Nykanen D, Zellers T. Fracture of the GORE HELEX septal occluder: associated factors and clinical outcomes. Catheter Cardiovasc Interv. 2009;73:941–8.

    Article  PubMed  Google Scholar 

  43. Sievert H, Babic UU, Hausdorf G, Schneider M, Höpp HW, Pfeiffer D, Pfisterer M, Friedli B, Urban P. Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (A multi-institutional European trial). Am J Cardiol. 1998;82:1405–13.

    Article  PubMed  CAS  Google Scholar 

  44. Kabus M, Hahn G, Nachtrodt G, Lorenz N, Kropp J, Göldner B, Hausdorf G. Late complication after transcatheter closure of an atrial septal defect. Z Kardiol. 2001;90:516–21.

    Article  PubMed  CAS  Google Scholar 

  45. Spies C, Strasheim R, Timmermanns I, Schraeder R. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder. Eur Heart J. 2006;27:365–71.

    Article  PubMed  Google Scholar 

  46. Mellert F, Preusse CJ, Haushofer M, Winkler K, Nill C, Pfeiffer D, Redel D, Lüderitz B, Welz A. Surgical management of complications caused by transcatheter ASD closure. Thorac Cardiovasc Surg. 2001;49:338–42.

    Article  PubMed  CAS  Google Scholar 

  47. Brown S, Gewillig M. Perforation of the aortic sinus after closure of atrial septal defects with the atriasept occluder. Catheter Cardiovasc Interv. 2009;74:298–301.

    Article  PubMed  Google Scholar 

  48. Rezaian GR, Amirghofran AA, Afifi S, Moaref AR, Rezaian S. Nitinol wire mesh fracture and traumatic left atrial thrombus in a patient with atrial septal defect amplatzer occluder. J Card Surg. 2011;26:41–3.

    Article  PubMed  Google Scholar 

  49. Trehan V, Mehta V, Mukhopadhyay S, Yusuf J, Arora R, Kaul UA. Constricting band: an unusual cause of incomplete expansion of Amplatzer septal occluder device. Catheter Cardiovasc Interv. 2004;61:418–21.

    Article  PubMed  Google Scholar 

  50. Ten Freyhaus H, Rosenkranz S, Südkamp M, Höpp HW. Dysfunction of an atrial septal defect occluder 8 years after implantation. J Intervent Cardiol. 2006;19:163–5.

    Article  PubMed  Google Scholar 

  51. Nishida K, Yoshimura S, Yazaki S, Echigo S, Kamiya T. Measurement of atrial septal defect size. Pediatr Cardiol Cardiac Surg. 1998;14:212. in Japanese.

    Google Scholar 

  52. McMahon CJ, Feltes TF, Fraley JK, Bricker JT, Grifka RG, Tortoriello TA, Blake R, Bezold LI. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart. 2002;87:256–9.

    Article  PubMed  CAS  Google Scholar 

  53. Tortoriello TA, McMahon C, Kovalchin JP, Bricker JT, Grifka RG. Growth of an atrial septal defect: missing the window for transcatheter closure. Pediatr Cardiol. 2002;23:542–4.

    Article  PubMed  CAS  Google Scholar 

  54. Maeno YV, Benson LN, McLaughlin PR, Boutin C. Dynamic morphology of the secundum atrial septal defect evaluated by three dimensional transoesophageal echocardiography. Heart. 2000;83:673–7.

    Article  PubMed  CAS  Google Scholar 

  55. Lodato JA, Cao QL, Weinert L, Sugeng L, Lopez J, Lang RM, Hijazi ZM. Feasibility of real-time three-dimensional transoesophageal echocardiography for guidance of percutaneous atrial septal defect closure. Eur J Echocardiogr. 2009;10:543–8.

    Article  PubMed  Google Scholar 

  56. Kort HW, Balzer DT, Johnson MC. Resolution of right heart enlargement after closure of secundum atrial septal defect with transcatheter technique. J Am Coll Cardiol. 2001;38:1528–32.

    Article  PubMed  CAS  Google Scholar 

  57. Pawelec-Wojtalik M, Wojtalik M, Mrowczynski W, Surmacz R, Quereshi SA. Comparison of cardiac function in children after surgical and Amplatzer occluder closure of secundum atrial septal defects. Eur J Cardiothorac Surg. 2006;29:89–92.

    Article  PubMed  Google Scholar 

  58. Veldtman GR, Razack V, Siu S, El-Hajj H, Walker F, Webb GD, Benson LN, McLaughlin PR. Right ventricular form and function after percutaneous atrial septal defect device closure. J Am Coll Cardiol. 2001;37:2108–13.

    Article  PubMed  CAS  Google Scholar 

  59. Cecconi M, Quarti A, Bianchini F, Bucari S, Costantini C, Giovagnoni A, Perna GP. Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg. 2006;81:e29–30.

    Article  PubMed  Google Scholar 

  60. López-Fernández T, Gómez De Diego JJ, Monedero MC, Cabestrero D, Mesa JM, Moreno I, Moreno Yangüela M, López De Sa E, López-Sendoón JL. Aortic wall erosion after percutaneous closure of atrial septal defect. J Am Soc Echocardiogr 2011;24:227.e225–227.e228.

  61. Ivens E, Hamilton-Craig C, Aroney C, Clarke A, Jalali H, Burstow DJ. Early and late cardiac perforation by Amplatzer atrial septal defect and patent foramen ovale devices. J Am Soc Echocardiogr. 2009;22:1067–70.

    Article  PubMed  Google Scholar 

  62. Zhu W, Neubauer H. Secondary residual shunt after atrial septal defect closure with an amplatzer occluder: surgical removal and evaluation of device biocompatibility after 7 years. Pediatr Cardiol. 2010;31:1107–10.

    Article  PubMed  Google Scholar 

  63. Walpot J, Amsel B, Rodrigus I, Pasteuning WH, Koeman J, Hokken R. Late infective endocarditis of an atrial septal occluder device presenting as a cystic mass. Echocardiography. 2011;28:e131–3.

    Article  PubMed  Google Scholar 

  64. Taggart NW, Dearani JA, Hagler DJ. Late erosion of an Amplatzer septal occluder device 6 years after placement. J Thorac Cardiovasc Surg. 2011;142:221–2.

    Article  PubMed  Google Scholar 

  65. Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003;139:753–60.

    PubMed  Google Scholar 

  66. O’Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. Circulation. 2009;119:2743–7.

    Article  PubMed  Google Scholar 

  67. Chan KC, Godman MJ, Walsh K, Wilson N, Redington A, Gibbs JL. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart. 1999;82:300–6.

    PubMed  CAS  Google Scholar 

  68. Perry YY, Triedman JK, Gauvreau K, Lock JE, Jenkins KJ. Sudden death in patients after transcatheter device implantation for congenital heart disease. Am J Cardiol. 2000;85:992–5.

    Article  PubMed  CAS  Google Scholar 

  69. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pomè G, Bossone E, Frigiola A. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol. 2002;39:1061–5.

    Article  PubMed  Google Scholar 

  70. Suda K, Raboisson MJ, Piette E, Dahdah NS, Miró J. Reversible atrioventricular block associated with closure of atrial septal defects using the amplatzer device. J Am Coll Cardiol. 2004;43:1677–82.

    Article  PubMed  Google Scholar 

  71. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 2004;63:496–502.

    Article  PubMed  Google Scholar 

  72. Amin Z. Transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv. 2006;68:778–87.

    Article  PubMed  Google Scholar 

  73. Shiraishi I. Adult congenital heart disease for cardiologists. Respir Circ. 2010;58:623–32. in Japanese.

    Google Scholar 

  74. Vojáček J, Mates M, Popelová J, Pavel P. Perforation of the right atrium and the ascending aorta following percutaneous transcatheter atrial septal defect closure. Interact Cardiovasc Thorac Surg. 2005;4:157–9.

    Article  PubMed  Google Scholar 

  75. Trepels T, Zeplin H, Sievert H, Billinger K, Krumsdorf U, Zadan E, Horvath K. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv. 2003;58:111–3.

    Article  PubMed  Google Scholar 

  76. Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol. 2005;45:1213–8.

    Article  PubMed  Google Scholar 

  77. Cikirikcioglu M, Cherian S, Lerch R, Licker MJ, Roffi M, Bonvini RF, Kalangos A. Late tamponade secondary to aortic root perforation by biostar septal closure device. Ann Thorac Surg. 2011;91:604–6.

    Article  PubMed  Google Scholar 

  78. Preventza O, Sampath-Kumar S, Wasnick J, Gold JP. Late cardiac perforation following transcatheter atrial septal defect closure. Ann Thorac Surg. 2004;77:1435–7.

    Article  PubMed  Google Scholar 

  79. Christen T, Mach F, Didier D, Kalangos A, Verin V, Trindade PT. Late cardiac tamponade after percutaneous closure of a patent foramen ovale. Eur J Echocardiogr. 2005;6:465–9.

    Article  PubMed  Google Scholar 

  80. Schoen SP, Wiedeman S, Bock M, Kappert U, Strasser RH. Interatrial septal closure devices and aortic perforation: a note of caution. J Invasive Cardiol. 2009;21:E39–41.

    PubMed  Google Scholar 

  81. El-Said HG, Moore JW. Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations? Catheter Cardiovasc Interv. 2009;73:925–30.

    Article  PubMed  Google Scholar 

  82. Girdauskas E, Diab M, Secknus MA, Borger MA, Kuntze T. Late cardiac perforation after transcatheter closure of patent foramen ovale mimicking acute type a aortic dissection. Ann Thorac Surg. 2010;89:1649–51.

    Article  PubMed  Google Scholar 

  83. Wilson WM, Goh TH, Oqueli E, Willis Y, Chan C, Skillington P, Grigg LE. Aorto-left atrial fistula post-percutaneous device ASD closure. Heart Lung Circ. 2010;19:53–5.

    Article  PubMed  CAS  Google Scholar 

  84. Kamouh A, Osman MN, Rosenthal N, Blitz A. Erosion of an Amplatzer septal occluder device into the aortic root. Ann Thorac Surg. 2011;91:1608–10.

    Article  PubMed  Google Scholar 

  85. Sauer HH, Ntalakoura K, Haun C, Le TP, Hraska V. Early cardiac perforation after atrial septal defect closure with the Amplatzer septal occluder. Ann Thorac Surg. 2006;81:2312–3.

    Article  PubMed  Google Scholar 

  86. Yared K, Baggish AL, Solis J, Durst R, Passeri JJ, Palacios IF, Picard MH. Echocardiographic assessment of percutaneous patent foramen ovale and atrial septal defect closure complications. Circ Cardiovasc Imaging. 2009;2:141–9.

    Article  PubMed  Google Scholar 

  87. Zaidi AN, Cheatham JP, Raman SV, Cook SC. Multislice computed tomographic findings in symptomatic patients after amplatzer septal occluder device implantation. J Intervent Cardiol. 2009;22:92–7.

    Article  PubMed  Google Scholar 

  88. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43:302–9.

    Article  PubMed  Google Scholar 

  89. Slavin L, Tobis JM, Rangarajan K, Dao C, Krivokapich J, Liebeskind DS. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol. 2007;99:1316–20.

    Article  PubMed  Google Scholar 

  90. Narayan V, Puri P, Mehra AO. Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation. J Invasive Cardiol. 2008;20:E247–9.

    PubMed  Google Scholar 

  91. Acar P, Aggoun Y, Abdel-Massih T. Thrombus after transcatheter closure of ASD with an Amplatzer septal occluder assessed by three dimensional echocardiographic reconstruction. Heart. 2002;88:52.

    Article  PubMed  CAS  Google Scholar 

  92. Willcoxson FE, Thomson JD, Gibbs JL. Successful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect occluder with abciximab and heparin. Heart (British Cardiac Society). 2004;90:e30.

    Article  CAS  Google Scholar 

  93. Yorgun H, Canpolat U, Kaya EB, Aytemir K, Oto A. Thrombus formation during percutaneous closure of an atrial septal defect with an amplatzer septal occluder. Tex Heart Inst J. 2011;38:427–30.

    PubMed  Google Scholar 

  94. Anzai H, Child J, Natterson B, Krivokapich J, Fishbein MC, Chan VK, Tobis JM. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol. 2004;93:426–31.

    Article  PubMed  Google Scholar 

  95. Braun M, Gliech V, Boscheria A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J. 2004;25:424–30.

    Article  PubMed  CAS  Google Scholar 

  96. Raghu A, Kawalsky D, Feldman M. Embolic Stroke due to a left atrial thrombus two years after placement of an atrial septal defect closure device. Am J Cardiol. 2006;98:1294–6.

    Article  PubMed  Google Scholar 

  97. Kudo Y, Suda K, Tananari Y. Headache and neurologic symptoms after implantation of Amplatzer septal occluder (ASO). Pediatr Cardiol Cardiac Surg. 2009;25:194. in Japanese.

    Google Scholar 

  98. Demkow M, Ruzyllo W, Konka M, Kepka C, Kowalski M, Wilczynski J, Rydlewska-Sadowska W. Transvenous closure of moderate and large secundum atrial septal defects in adults using the amplatzer septal occluder. Catheter Cardiovasc Interv. 2001;52:188–93.

    Article  PubMed  CAS  Google Scholar 

  99. Prewitt KC, Gaither NS, Farb A, Wortham DC. Transient ischemic attacks after long-term clamshell occluder implantation for closure of atrial septal defect. Am Heart J. 1992;124:1394–7.

    Article  PubMed  CAS  Google Scholar 

  100. Rodés-Cabau J, Molina C, Serrano-Munuera C, Casaldáliga J, Alvarez-Sabin J, Evangelista A, Soler–Soler J. Migraine with aura related to the percutaneous closure of an atrial septal defect. Catheter Cardiovasc Interv. 2003;60:540–2.

    Article  PubMed  Google Scholar 

  101. Sharifi M, Dehghani M, Mehdipour M, Al-Bustami O, Emrani F, Burks J. Intense migraines secondary to percutaneous closure of atrial septal defects. J Intervent Cardiol. 2005;18:181–3.

    Article  PubMed  Google Scholar 

  102. Yazaki S, Kitano M, Nii M, Yamada O, Kimura K, Echigo S. ASD closure with the Amplatzer septal occluder—technical consideration. Pediatr Cardiol Cardiac Surg. 2007;23:455–62. in Japanese.

    Google Scholar 

  103. Nakanishi T. Percutaneous closure of a secondum atrial septal defect. Pediatr Jpn. 2010;51:377–82. in Japanese.

    Google Scholar 

  104. Tomita H, Hatakeyama K, Soda W, Kobayashi T. Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. J Cardiol. 2007;49:357–60.

    PubMed  Google Scholar 

  105. Itoh S, Suda K, Kishimoto S, Nishino H, Kudo Y, Iemura M, Teramachi Y, Matsuishi T, Yasunaga H. Microembolic signals measured by transcranial Doppler during transcatheter closure of atrial septal defect using the Amplatzer septal occluder. Cardiol Young. 2011;21:182–6.

    Article  PubMed  Google Scholar 

  106. Noishiki Y, Tomizawa Y, Yamane Y, Matsumoto A. The vicious cycle of nonhealing neointima in fabric vascular prostheses. Artif Organs. 1995;19:7–16.

    Article  PubMed  CAS  Google Scholar 

  107. Oshida E, Matsumoto Y, Chikuda M. A case of Purtscher’s-like retinopathy following surgery for dissecting aortic aneurysm. Atarashii Ganka. 2003;20:1457–60. In Japanese.

    Google Scholar 

  108. Moiduddin N, Cheatham JP, Hoffman TM, Phillips AB, Kovalchin JP. Amplatzer Septal occluder associated with late pulmonary venous obstruction requiring surgical removal with acquired aorta to left atrial fistula. Am J Cardiol. 2009;103:1039–40.

    Article  PubMed  Google Scholar 

  109. Lambert V, Belli E, Plot JD, Planché C, Losay J. Haemolysis, a rare complication after percutaneous closure of atrial septal defect. Arch Mal Coeur Vaiss. 2000;93:623–5.

    PubMed  CAS  Google Scholar 

  110. Aggoun Y, Gallet B, Acar P, Pulik M, Czitrom D, Lagier A, Laborde F. Perforation of the aorta after percutaneous closure of an atrial septal defect with an Amplatz occluder, presenting with acute severe haemolysis. Arch Mal Coeur Vaiss. 2002;95:479–82.

    PubMed  CAS  Google Scholar 

  111. Sey MSL, Manlucu J, Myers KA. Intravascular hemolysis secondary to aorto-atrial fistula presenting as red urine. J Gen Intern Med. 2010;25:1370–4.

    Article  PubMed  Google Scholar 

  112. Venugopal P, Fallouh H, Anderson D. Late embolization to the aortic arch of an Amplatzer Device used to occlude a baffle leak. J Thorac Cardiovasc Surg 2010;139.

  113. Duygu H, Akyildiz ZI, Kocabas U, Nazli C, Ergene O. Silent embolization of an Amplatzer atrial septal closure device into the main pulmonary artery: pivotal role of routine postprocedural surveillance echocardiography. Int J Cardiol. 2011;148:235–7.

    Article  PubMed  Google Scholar 

  114. Motreff P, Dauphin C, Souteyrand G. Cardiac perforation and tamponade 3 months after transcatheter PFO closure by STARFlex device: a case report. Catheter Cardiovasc Interv. 2008;71:412–6.

    Article  PubMed  Google Scholar 

  115. Mashman WE, King SB, Jacobs WC, Ballard WL. Two cases of late embolization of Amplatzer septal occluder devices to the pulmonary artery following closure of secundum atrial septal defects. Catheter Cardiovasc Interv. 2005;65:588–92.

    Article  PubMed  Google Scholar 

  116. Verma PK, Thingnam SKS, Sharma A, Taneja JS, Varma JS, Grover A. Delayed embolization of Amplatzer septal occluder device: an unknown entity. A case report. Angiology. 2003;54:115–8.

    Google Scholar 

  117. Tsilimingas NB, Reiter B, Kodolitsch YV, Münzel T, Meinertz T, Hofmann T. Surgical revision of an uncommonly dislocated self-expanding Amplatzer septal occluder device. Ann Thorac Surg. 2004;78:686–7.

    Article  PubMed  Google Scholar 

  118. Grayburn PA, Schwartz B, Anwar A, Hebeler RF Jr. Migration of an amplatzer septal occluder device for closure of atrial septal defect into the ascending aorta with formation of an aorta-to-right atrial fistula. Am J Cardiol. 2005;96:1607–9.

    Article  PubMed  Google Scholar 

  119. Levi DS, Moore JW. Embolization and Retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv. 2004;61:543–7.

    Article  PubMed  Google Scholar 

  120. Lysitsas DN, Wrigley B, Banerjee P, Glennon PE, Parmar JM, Shiu MF, Been M. Presentation of an embolised Amplatzer septal occluder to the main pulmonary artery 2 years after implantation. Int J Cardiol. 2009;131:e106–7.

    Article  PubMed  Google Scholar 

  121. Contrafouris CA, Chatzis AC, Giannopoulos NM, Milonakis M, Kousi T, Kirvassilis G, Sarris GE. Emergency surgical intervention for runaway atrial septal defect closure devices: a word of caution. J Thorac Cardiovasc Surg. 2006;132:1234–5.

    Article  PubMed  Google Scholar 

  122. Ito R, Mizuno Y, Miyamoto Y, Miwa T, Ka K. Embolization of Amplatzer Septal Occuluder (ASO) to right ventricle diagnosed by arrhythmia: a case. JJSCA. 2011;31:S352. in Japanese.

    Google Scholar 

  123. Carlson KM, Justino H, O’Brien RE, Dimas VV, Leonard GT Jr, Pignatelli RH, Mullins CE, Smith EO, Grifka RG. Transcatheter atrial septal defect closure: modified balloon sizing technique to avoid overstretching the defect and oversizing the amplatzer septal occluder. Catheter Cardiovasc Interv. 2005;66:390–6.

    Article  PubMed  Google Scholar 

  124. Schoen SP, Boscheri A, Lange SA, Braun MU, Fuhrmann J, Kappert U, Strasser RH. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale. Heart. 2008;94:844–7.

    Article  PubMed  CAS  Google Scholar 

  125. Li W, Han W, Yu C, Zhang C, Tu Z, Wu S, Huber CH, Ma L. Severe mitral valve insufficiency after transcatheter atrial septal defect closure with the amplatzer septal occluder: a device-related complication. J Card Surg. 2009;24:672–4.

    Article  PubMed  Google Scholar 

  126. Sabiniewicz R, Ciećwierz D, Meyer-Szary J, Erecinśki J. Massive intravascular haemolysis after percutaneous atrial septal defect closure. Masywna hemoliza wewnątrznaczyniowa po interwencyjnym leczeniu ubytku w przegrodzie miȩdzyprzedsionkowej 2012;70:58–59.

    Google Scholar 

  127. Chessa M, Butera G, Frigiola A, Carminati M. Endothelialization of ASD devices for transcatheter closure: possibility or reality? Int J Cardiol. 2004;97:563–4.

    Article  PubMed  Google Scholar 

  128. Wilson NJ, Smith J, Prommete B, O’Donnell C, Gentles TL, Ruygrok PN. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias. Heart Lung Circ. 2008;17:318–24.

    Article  PubMed  Google Scholar 

  129. Hill K, Christian K, Kavanaugh-Mchugh A, Doyle T. Right-sided pulmonary venous obstruction between a right aortic arch and an Amplatzer septal occlusion device following closure of a secundum atrial septal defect. Pediatr Cardiol. 2009;30:855–7.

    Article  PubMed  Google Scholar 

  130. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation. 2007;116:1736–54.

    Article  PubMed  Google Scholar 

  131. Carminati M, Chessa M, Butera G, Bini RM, Giusti S, Festa P, Spadoni I, Redaelli S, Hausdorf G. Transcatheter closure of atrial septal defects with the STARFlex device: early results and follow-up. J Intervent Cardiol. 2001;14:319–24.

    Article  PubMed  CAS  Google Scholar 

  132. Hopkins RA, Bert AA, Buchholz B, Guarino K, Meyers M. Surgical patch closure of atrial septal defects. Ann Thorac Surg. 2004;77:2144–9.

    Article  PubMed  Google Scholar 

  133. Köster R, Vieluf D, Kiehn M, Sommerauer M, Kahler J, Baldus S, Meinertz T, Hamm CW. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet. 2000;356:1895–7.

    Article  PubMed  Google Scholar 

  134. Hillen U, Haude M, Erbel R, Goos M. Evaluation of metal allergies in patients with coronary stents. Contact Dermatitis. 2002;47:353–6.

    Article  PubMed  CAS  Google Scholar 

  135. Giménez-Arnau A, Riambau V, Serra-Baldrich E, Camarasa JG. Metal-induced generalized pruriginous dermatitis and endovascular surgery. Contact Dermatitis. 2000;43:35–40.

    Article  PubMed  Google Scholar 

  136. Kim KH, Park JC, Yoon NS, Moon JY, Hong YJ, Park HW, Kim JH, Ahn Y, Jeong MH, Cho JG, Kang JC. A case of allergic contact dermatitis following transcatheter closure of patent ductus arteriosus using Amplatzer ductal occluder. Int J Cardiol. 2008;127:e98–9.

    Article  PubMed  Google Scholar 

  137. Rigatelli G, Cardaioli P, Giordan M, Aggio S, Chinaglia M, Braggion G, Roncon L. Nickel allergy in interatrial shunt device-based closure patients. Congenit Heart Dis. 2007;2:416–20.

    Article  PubMed  Google Scholar 

  138. Lai DW, Saver JL, Araujo JA, Reidl M, Tobis J. Pericarditis associated with nickel hypersensitivity to the amplatzer occluder device: a case report. Catheter Cardiovasc Interv. 2005;66:424–6.

    Article  PubMed  Google Scholar 

  139. Burian M, Neumann T, Weber M, Brandt R, Geisslinger G, Mitrovic V, Hamm C. Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder. Int J Clin Pharmacol Ther. 2006;44:107–12.

    PubMed  CAS  Google Scholar 

  140. Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am Heart J. 2003;145:737–41.

    Article  PubMed  CAS  Google Scholar 

  141. Tomizawa Y, Hanawa T, Kuroda D, Nishida H, Endo M. Corrosion of stainless steel sternal wire after long-term implantation. J Artif Organs. 2006;9:61–6.

    Article  PubMed  CAS  Google Scholar 

  142. Vincent RN, Raviele AA, Diehl HJ. Single-center experience with the HELEX™ septal occluder for closure of atrial septal defects in children. J Intervent Cardiol. 2003;16:79–82.

    Article  PubMed  Google Scholar 

  143. Kong H, Wilkinson JL, Coe JY, Gu X, Urness M, Kim TH, Bass JL. Corrosive behaviour of Amplatzer® devices in experimental and biological environments. Cardiol Young. 2002;12:260–5.

    Article  PubMed  Google Scholar 

  144. Guidoin R, Marois Y, Douville Y, King MW, Castonguay M, Traore A, Formichi M, Staxrud LE, Norgren L, Bergeron P, Becquemin JP, Egana JM, Harris PL. First-generation aortic endografts: analysis of explanted Stentor devices from the EUROSTAR registry. J Endovasc Ther. 2000;7:105–22.

    Article  PubMed  CAS  Google Scholar 

  145. Tomizawa Y, Hanawa T. Corrosion of pure titanium sternal wire. Ann Thorac Surg. 2007;84:1012–4.

    Article  PubMed  Google Scholar 

  146. Wertman B, Azarbal B, Riedl M, Tobis J. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol. 2006;47:1226–7.

    Article  PubMed  Google Scholar 

  147. Fukahara K, Minami K, Reiss N, Fassbender D, Koerfer R. Systemic allergic reaction to the percutaneous patent foramen ovale occluder. J Thorac Cardiovasc Surg. 2003;125:213–4.

    Article  PubMed  Google Scholar 

  148. Khodaverdian RA, Jones KW. Metal allergy to Amplatzer occluder device presented as severe bronchospasm. Ann Thorac Surg. 2009;88:2021–2.

    Article  PubMed  Google Scholar 

  149. Singh HR, Turner DR, Forbes TJ. Nickel allergy and the Amplatzer septal occluder. J Invasive Cardiol. 2004;16:681–2.

    PubMed  Google Scholar 

  150. Rabkin DG, Whitehead KJ, Michaels AD, Powell DL, Karwande SV. Unusual presentation of nickel allergy requiring explantation of an Amplatzer atrial septal occluder device. Clin Cardiol. 2009;32:E55–7.

    Article  PubMed  Google Scholar 

  151. Verma SK, Tobis JM. Explantation of patent foramen ovale closure devices: a multicenter survey. JACC Cardiovasc Interv. 2011;4:579–85.

    Article  PubMed  Google Scholar 

  152. Dasika UK, Kanter KR, Vincent R. Nickel allergy to the percutaneous patent foramen ovale occluder and subsequent systemic nickel allergy. J Thorac Cardiovasc Surg. 2003;126:2112.

    Article  PubMed  Google Scholar 

  153. Latson LA, Jones TK, Jacobson J, Zahn E, Rhodes JF. Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder. Am Heart J 2006;151:1129.e7–11.

    Google Scholar 

  154. Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol. 2006;110:7–14.

    Article  PubMed  Google Scholar 

  155. Sarris GE, Kirvassilis G, Zavaropoulos P, Belli E, Berggren H, Carrel T, Comas JV, Corno AF, Daenen W, Di Carlo D, Ebels T, Fragata J, Hamilton L, Hraska V, Jacobs J, Lazarov S, Mavroudis C, Metras D, Rubay J, Schreiber C, Stellin G. Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association. Eur J Cardiothorac Surg. 2010;37:1285–90.

    Article  PubMed  Google Scholar 

  156. Berdat PA, Chatterjee T, Pfammatter JP, Windecker S, Meier B, Carrel T. Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg. 2000;120:1034–9.

    Article  PubMed  CAS  Google Scholar 

  157. DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg. 2009;137:1334–41.

    Article  PubMed  Google Scholar 

  158. Walther T, Binner C, Rastan A, Dähnert I, Doll N, Falk V, Mohr FW, Kostelka M. Surgical atrial septal defect closure after interventional occluder placement: incidence and outcome. J Thorac Cardiovasc Surg. 2007;134:731–7.

    Article  PubMed  Google Scholar 

  159. Majunke N, Bialkowski J, Wilson N, Szkutnik M, Kusa J, Baranowski A, Heinisch C, Ostermayer S, Wunderlich N, Sievert H. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol. 2009;103:550–4.

    Article  PubMed  Google Scholar 

  160. Wang JK, Tsai SK, Wu MH, Lin MT, Lue HC. Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer septal occluder. Am Heart J. 2004;148:511–7.

    Article  PubMed  Google Scholar 

  161. Knott-Craig CJ, Goldberg SP. Emergent surgical retrieval of embolized atrial septal defect closure device. Ann Thorac Surg. 2008;85:319–21.

    Article  PubMed  Google Scholar 

  162. Costache V, Chavanon O, Thony F, Blin D. Aortic arch embolization of an Amplatzer® occluder after an atrial septal defect closure: hybrid operative approach without circulatory arrest. Eur J Cardiothorac Surg. 2005;28:340–2.

    Article  PubMed  Google Scholar 

  163. Lange SA, Schoen SP, Braun MU, Schulze MR, Boscheri AF, Kittner T, Strasser RH. Perforation of aortic root as secondary complication after implantation of patent foramen ovale occlusion device in a 31-year-old woman. J Intervent Cardiol. 2006;19:166–9.

    Article  PubMed  Google Scholar 

  164. Konstantinov IE, Saxena P, Friederich L, Newman MAJ. Emergency surgery after failed device closure of the atrial septal defect. J Thorac Cardiovasc Surg. 2007;133:1370–1.

    Article  PubMed  Google Scholar 

  165. Vogel M, Berger F, Dähnert I, Ewert P, Lange PE. Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder. Cardiol Young. 2000;10:534–7.

    PubMed  CAS  Google Scholar 

  166. Ishido H, Kobayashi T, Matsunaga T. Informed consent before Amplatzer septal occluder (ASO) implantation at our hospital. Pediatr Cardiol Cardiac Surg. 2009;25:205. in Japanese.

    Google Scholar 

  167. Department of Cardiology, Okayama University School of Medicine. For patients: transcatheter closure of atrial septal defect. http://cardio.icn.jp/k/05.html. Retrieved May 1, 2012 (in Japanese).

  168. To patients and general public: potential complications from the treatment. http://www.sjm.co.jp/general/amplatzer/chapter_04.html. Retrieved May 1, 2012 (in Japanese).

  169. Transcatheter closure of atrial septal defect using an Amplatzer septal occluder system. http://www.naganoch.gr.jp/cardiology/aso.pdf. Retrieved May 1, 2012 (in Japanese).

  170. Kuhn MA, Latson LA, Cheatham JP, McManus B, Anderson JM, Kilzer KL, Furst J. Biological response to Bard Clamshell septal occluders in the canine heart. Circulation. 1996;93:1459–63.

    Article  PubMed  CAS  Google Scholar 

  171. Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix. J Am Coll Cardiol. 2006;48:161–9.

    Article  PubMed  Google Scholar 

  172. Sigler M, Jux C. Biocompatibility of septal defect closure devices. Heart. 2007;93:444–9.

    Article  PubMed  Google Scholar 

  173. Qureshi AM, Mumtaz MA, Latson LA. Partial prolapse of a HELEX device associated with early frame fracture and mitral valve perforation. Catheter Cardiovasc Interv. 2009;74:777–82.

    Article  PubMed  Google Scholar 

  174. Zaidi AN, Cheatham JP, Galantowicz M, Astor T, Kovalchin JP. Late thrombus formation on the Helex septal occluder after double-lung transplant. J Heart Lung Transplant. 2010;29:814–6.

    Article  PubMed  Google Scholar 

  175. Jones TK, Latson LA, Zahn E, Fleishman CE, Jacobson J, Vincent R, Kanter K. Results of the U.S. Multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects. J Am Coll Cardiol. 2007;49:2215–21.

    Article  PubMed  Google Scholar 

  176. Knirsch W, Dodge-Khatami A, Balmer C, Peuster M, Kadner A, Weiss M, Prêtre R, Berger F. Aortic sinus-left atrial fistula after interventional closure of atrial septal defect. Catheter Cardiovasc Interv. 2005;66:10–3.

    Article  PubMed  Google Scholar 

  177. Chun DS, Turrentine MW, Moustapha A, Hoyer MH. Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc Interv. 2003;58:246–51.

    Article  PubMed  Google Scholar 

  178. Knepp MD, Rocchini AP, Lloyd TR, Aiyagari RM. Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder. Congenit Heart Dis. 2010;5:32–7.

    Article  PubMed  Google Scholar 

  179. Maimon MS, Ratnapalan S, Do A, Kirsh JA, Wilson GJ, Benson LN. Cardiac perforation 6 weeks after percutaneous atrial septal defect repair using an Amplatzer septal occluder. Pediatrics. 2006;118:e1572–5.

    Article  PubMed  Google Scholar 

  180. Kefer J, Sluysmans T, Hermans C, Khoury RE, Lambert C, Van De Wyngaert F, Ovaert C, Pasquet A. Percutaneous transcatheter closure of interatrial septal defect in adults: procedural outcome and long-term results. Catheter Cardiovasc Interv. 2012;79:322–30.

    Article  PubMed  Google Scholar 

  181. Lodha A, Haran M, Enakpene E, Sadiq A, Shani J. Cor triatriatum dextro iatrogenica: an unusual complication of atrial septal defect closure device. Echocardiography. 2012;29:E45–7.

    Article  PubMed  Google Scholar 

  182. Delaney JW, Li JS, Rhodes JF. Major complications associated with transcatheter atrial septal occluder implantation: a review of the medical literature and the manufacturer and user facility device experience (MAUDE) database. Congenit Heart Dis. 2007;2:256–64.

    Article  PubMed  Google Scholar 

  183. Martin GR, Beekman RH, Ing FF, Jenkins KJ, McKay CR, Moore JW, Ringel RE, Rome JJ, Ruiz CE, Vincent RN. The IMPACT registry™: improving pediatric and adult congenital treatments. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2010;13:20–5.

    Article  PubMed  Google Scholar 

  184. Murphy JC, Walsh SJ, Spence MS. Late aortic perforation with an atriasept device resulting in life-threatening tamponade. Catheter Cardiovasc Interv. 2010;76:132–4.

    Article  PubMed  Google Scholar 

  185. Slottow TLP, Steinberg DH, Waksman R. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices. Circulation. 2007;116:677–82.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Surgery, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Yasuko Tomizawa

Authors
  1. Yasuko Tomizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuko Tomizawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomizawa, Y. Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs. J Artif Organs 15, 311–324 (2012). https://doi.org/10.1007/s10047-012-0651-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-012-0651-7

Keywords

Search

Navigation